A Phase 2 Study of Nivolumab for Relapsed/Refractory Multiple Myeloma or Non-Hodgkin Lymphoma Following CAR-T Therapy
Banerjee, Rahul, Lynch, Ryan C, Wu, Qian, Simon, Sylvain, Ujjani, Chaitra S, Till, Brian G, Wuliji, Natalie, Gausman, Daria, Dizon, Joshua, Kwok, Mary L., Lee, Sarah S., Silbermann, Rebecca, Medvedova, Eva, Maloney, David G, Ramos, Jorge Daniel, Shadman, Mazyar, Gauthier, Jordan, Turtle, Cameron J., Gopal, Ajay K, Green, Damian J, Riddell, Stanley R., Cowan, Andrew J.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Colonic Extramedullary Leukemia: A Liquid Tumor Solidified: 1449
Skaret, Michael M., Kwok, Mary L., Singla, Manish B., Armbruster, Steven P.
Published in The American journal of gastroenterology (01.10.2016)
Published in The American journal of gastroenterology (01.10.2016)
Get full text
Journal Article
Treatment of High Risk (HR) Smoldering Multiple Myeloma (SMM) with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Lenalidomide Maintenance (-R): A Phase 2 Clinical and Correlative Study
Kazandjian, Dickran, Hill, Elizabeth, Morrison, Candis, Dew, Alexander, Korde, Neha, Mailankody, Sham, Manasanch, Elisabet E., Kwok, Mary L., Bhutani, Manisha, Tageja, Nishant, Zhang, Yong, Carpenter, Ashley, Epstein, Monica, Emanuel, Michael, Lu, Crystal, Braylan, Raul C., Calvo, Katherine R., Choyke, Peter, Dulau-Florea, Alina, Mena, Esther, Lindenberg, Liza, Maric, Irina, Patel, Nisha, Stetler-Stevenson, Maryalice, Wang, Hao-Wei, Yuan, Constance M., Steinberg, Seth M., Figg, William D., Roschewski, Mark, Landgren, Ola
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term Deep Remissions and Prolonged Progression-Free Duration Regardless of Age or Cytogenetic Risk after 5 Years of Follow up
Kazandjian, Dickran, Korde, Neha, Mailankody, Sham, Zhang, Yong, Hsu, Jennifer, Hill, Elizabeth, Morrison, Candis, Divakarla, Sneha, Kwok, Mary L., Manasanch, Elisabet E., Bhutani, Manisha, Tageja, Nishant, Galera, Pallavi, Dulau-Florea, Alina, Salem, Dalia, Gonzalez, Esther, Lindenberg, Liza, Maric, Irina, Calvo, Katherine R., Braylan, Raul C., Yuan, Constance, Wilson, Wyndham H., Choyke, Peter, Stetler-Stevenson, Maryalice, Steinberg, Seth M., Figg, William, Roschewski, Mark, Landgren, Ola
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Post-CAR-T Checkpoint Inhibition Can Result in Durable Responses in a Minority of Patients with Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL): Results of a Phase 2 Study of Nivolumab after CAR-T Failure
Banerjee, Rahul, Lynch, Ryan C, Wu, Qian Vicky, Simon, Sylvain, Ujjani, Chaitra S, Till, Brian G, Wuliji, Natalie, Gausman, Daria, Dizon, Joshua, Kwok, Mary L., Lee, Sarah S., Silbermann, Rebecca W, Medvedova, Eva, Maloney, David G., Ramos, Jorge, Shadman, Mazyar, Gauthier, Jordan, Turtle, Cameron J., Gopal, Ajay K, Green, Damian J., Riddell, Stanley R., Cowan, Andrew J.
Published in Transplantation and cellular therapy (01.02.2024)
Published in Transplantation and cellular therapy (01.02.2024)
Get full text
Journal Article
Sustained Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R): Updated Results of a Phase 2 Study
Kazandjian, Dickran, Korde, Neha S, Roschewski, Mark, Mailankody, Sham, Morrison, Candis, Manasanch, Elisabet E., Kwok, Mary L, Tageja, Nishant, Bhutani, Manisha, Zingone, Adriana, Costello, Rene, Zhang, Yong, Mulquin, Marcia, Lamping, Liz, Carpenter, Ashley, Roberson, Brenda, Maric, Irina, Calvo, Katherine R., Braylan, Raul C, Yuan, Constance M., Stetler-Stevenson, Maryalice, Arthur, Diane C., Lindenberg, Liza, Kurdziel, Karen A., Choyke, Peter, Steinberg, Seth M., Figg, William, Wilson, Wyndham H., Landgren, Ola
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Sustained High Rates of Complete Response and Minimal Residual Disease Negativity after 8 Cycles of Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (DEX) Followed By 2 Years of Lenalidomide Maintenance (CRd-R) in Patients with High-Risk Smoldering Multiple Myeloma: Updated Results of Clinical and Correlative Phase 2 Study
Kazandjian, Dickran, Korde, Neha S, Roschewski, Mark, Mailankody, Sham, Morrison, Candis, Manasanch, Elisabet E., Kwok, Mary L, Tageja, Nishant, Bhutani, Manisha, Zingone, Adriana, Costello, Rene, Zhang, Yong, Mulquin, Marcia, Lamping, Liz, Carpenter, Ashley, Roberson, Brenda, Maric, Irina, Calvo, Katherine R., Braylan, Raul C, Yuan, Constance M., Stetler-Stevenson, Maryalice, Arthur, Diane C., Lindenberg, Liza, Kurdziel, Karen A., Choyke, Peter, Steinberg, Seth M., Figg, William, Wilson, Wyndham H., Landgren, Ola
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Minimal Residual Disease (MRD) Testing in Newly Diagnosed Multiple myeloma (MM) Patients: A Prospective Head-to-Head Assessment of Cell-Based, Molecular, and Molecular-Imaging Modalities
Korde, Neha, Mailankody, Sham, Roschewski, Mark, Faham, Malek, Kotwaliwale, Chitra, Moorhead, Martin, Kwok, Mary L, Manasanch, Elisabet E., Bhutani, Manisha, Tageja, Nishant, Kazandjian, Dickran, Costello, Rene, Zhang, Yong, Zingone, Adriana, Burton, Debbie, Mulquin, Marcia, Carpenter, Ashley, Zuchlinski, Diamond, Lamping, Elizabeth, Carter, George, Morrison, Candis, Kurdziel, Karen, Lindenberg, Maria, Kurlander, Roger, Maric, Irina, Calvo, Katherine R., Braylan, Raul C, Yuan, Constance, Stetler-Stevenson, Maryalice, Arthur, Diane C, Steinberg, Seth M., Figg, William D, Choyke, Peter, Landgren, Ola
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Altered Plasma Cell Characteristics in Smoldering Myeloma and MGUS Patients with Preceding Immune-Related Conditions
Kwok, Mary L, Korde, Neha, Manasanch, Elisabet E., Flanders, Aaron W., Maric, Irina, Calvo, Katherine R, Zingone, Adriana, Costello, Rene, Cordaro, Daniel, Sato, Audrey, Mulquin, Marcia, Zuchlinski, Diamond, Roschewski, Mark, Landgren, Ola
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients
Korde, Neha, Zingone, Adriana, Kwok, Mary L, Manasanch, Elisabet E., Bhutani, Manisha, Tageja, Nishant, Kazandjian, Dickran, Mailankody, Sham, Costello, Rene, Zhang, Yong, Burton, Debra, Carter, George, Wu, Peter, Mulquin, Marcia, Zuchlinski, Diamond, Maric, Irina, Calvo, Katherine R, Braylan, Raul C., Roschewski, Mark, Yuan, Constance, Stetler-Stevenson, Maryalice, Arthur, Diane C, Lindenberg, Liza, Kurdziel, Karen, Choyke, Pete, Steinberg, Seth M., Landgren, Ola
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article